Medtech is vital to a healthier America
In this op-ed published in The Washington Times, AdvaMed President and CEO Scott Whitaker highlights the critical role of medtech in addressing America’s chronic disease epidemic and improving public health. With innovations ranging from AI-powered cancer screenings to life-saving wearables, Whitaker highlights how medtech is extending life expectancy, reducing hospital stays, and enhancing the quality of life for millions of Americans
With 95 percent of medtech R&D taking place in the U.S. and three million American jobs supported by the industry, medtech is a domestic powerhouse in manufacturing, innovation and exports. Whitaker urges policymakers to adopt measures that expand patient access to medtech, improve Medicare coverage of the latest medtech, and maintain flexibility on tariffs on medtech for humanitarian reasons.
This op-ed offers valuable insight into AdvaMed’s advocacy priorities and the vital contributions of medtech to the administration’s “Make America Healthy Again” initiative.